Research Article
Persistent Increased Frequency of Genomic Instability in Women Diagnosed with Breast Cancer: Before, during, and after Treatments
Table 1
Damage index and micronucleus frequency (mean ± SD) during diagnostic of breast cancer in relation to clinical characteristics of patients.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
aKi-67 = proliferation index: Ki-67 < 10% is low; Ki-67 of 10–25 is moderate; Ki-67 > 25 is high; bFAC: fluorouracil, doxorubicin, and cyclophosphamide; cAC-T: doxorubicin, cyclophosphamide, and taxol; RT: radiotherapy; QT: chemotherapy; n: number of individuals with the characteristic. Significant at in relation to progesterone positive receptor; in relation to estrogen positive receptor; Mann Whitney U test was the test applied to evaluate the table's variables. |